Archive - June 2018
Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report
Accord Healthcare Continue Expansion into Europe
Boehringer’s Spiriva gets UK license for young asthma patients
High court rejects homeopathy plea
UK health spends lags behind EU peers
NICE deems MSD’s Keytruda cost-effective as first-line lung cancer therapy
Pfizer unveils $600m investment in venture capital arm
Building a Key Account Organization: 5 Power Questions